KRT5 and breast papillary carcinoma: Similar challenges have been reported in other epithelial malignancies, such as papillary breast carcinoma, where the absence of standardized immunohistochemical markers can hinder the distinction between in situ and invasive disease, highlighting the decisive role of markers such as SMA, p63, and CK5/6 in diagnostic accuracy [47].